Causes: Health
Mission: To pioneer a paradigm shift towards innovative, evidence-based research methods by bringing together scientists, policy makers, investors, and entrepreneurs to transform the biomedical sciences. We champion technologies that are better for humans and that replace animal testing.
Results: 2021 Highlights:(1) Scientific lead in getting the FDA Modernization Act of 2021 (H. R. 2565 — 117th Congress (2021-2022)) introduced to the U. S. Senate. (2) Held the first workshop in our Breakthrough series for Parkinson's Disease. (3) Formed a collaboration with the Glass Wall Syndicate to begin connecting investors to scientific innovators. (4) Established the first CCS Investor Summit which will be held on February 2022 to introduce investors in the growing sector of non-animal methods for research and testing.
Target demographics: Improving human health and the environment by replacing animal testing with innovative human-based biology methods.
Direct beneficiaries per year: CCS reached an audience of 138,000 and had consultative discussions with 74 partners.
Geographic areas served: North America
Programs: Science and TechnologyCCS discovers and builds bridges between scientific research, innovation, funding, and talent gaps across the medical research testing environment. Academic AffairsCCS will work with academic institutions to ensure that students in the medical and life sciences or interested in joining the fields are sufficiently educated about human-based research, and to encourage their participation in this field in their careers. PolicyCCS Policy advocates for fair and progressive federal and state regulations, legislation, and governmental funding of and investment in human-specific testing methods. Corporate EngagementOur Corporate Engagement program will develop relationships with national and global chemical, pharmaceutical, and medical companies. Business InnovationCCS’s Business Innovation will help spur further innovation by facilitating workshops, conferences, and help-a-thons to increase knowledge sharing and collaboration that leads to greater market use and expansion of new technologies.
Mission: To pioneer a paradigm shift towards innovative, evidence-based research methods by bringing together scientists, policy makers, investors, and entrepreneurs to transform the biomedical sciences. We champion technologies that are better for humans and that replace animal testing.
Results: 2021 Highlights:(1) Scientific lead in getting the FDA Modernization Act of 2021 (H. R. 2565 — 117th Congress (2021-2022)) introduced to the U. S. Senate. (2) Held the first workshop in our Breakthrough series for Parkinson's Disease. (3) Formed a collaboration with the Glass Wall Syndicate to begin connecting investors to scientific innovators. (4) Established the first CCS Investor Summit which will be held on February 2022 to introduce investors in the growing sector of non-animal methods for research and testing.
Target demographics: Improving human health and the environment by replacing animal testing with innovative human-based biology methods.
Direct beneficiaries per year: CCS reached an audience of 138,000 and had consultative discussions with 74 partners.
Geographic areas served: North America
Programs: Science and TechnologyCCS discovers and builds bridges between scientific research, innovation, funding, and talent gaps across the medical research testing environment. Academic AffairsCCS will work with academic institutions to ensure that students in the medical and life sciences or interested in joining the fields are sufficiently educated about human-based research, and to encourage their participation in this field in their careers. PolicyCCS Policy advocates for fair and progressive federal and state regulations, legislation, and governmental funding of and investment in human-specific testing methods. Corporate EngagementOur Corporate Engagement program will develop relationships with national and global chemical, pharmaceutical, and medical companies. Business InnovationCCS’s Business Innovation will help spur further innovation by facilitating workshops, conferences, and help-a-thons to increase knowledge sharing and collaboration that leads to greater market use and expansion of new technologies.
contact@contemporarysciences.org
9841 Washingtonian Blvd Ste 200, Gaithersburg, MD 20878
775-388-2021
Health
Gaithersburg
